Xu, W. (2026). CRISPR/Cas9-Mediated PD-1 Engineered T Cells: New Strategy to Block Tumor Immune Escape. International Journal of Biology and Life Sciences, 16(1), 252-255. https://doi.org/10.54097/edfqwy74